Trials / Sponsors / QuantumLeap Healthcare Collaborative
QuantumLeap Healthcare Collaborative
Academic / Other · 5 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as T Ductal Carcinoma in Situ | Phase 2 | 2024-02-17 |
| Recruiting | PRE-I-SPY Phase I/Ib Oncology Platform Program HER2-positive Breast Cancer, Metastatic Cancer, Metastatic Breast Cancer | Phase 1 | 2023-02-15 |
| Withdrawn | ISPY-P1.01:Evaluating the Safety of Weekly Paclitaxel With Trastuzumab Duocarmazine (SYD985) in Patients With HER2-positive Breast Cancer, HER2 Low, SYD-985 | Phase 1 | 2021-07-28 |
| Active Not Recruiting | I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients COVID-19 | Phase 2 | 2020-07-31 |
| Recruiting | I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer Breast Neoplasms, Breast Cancer, Breast Tumors | Phase 2 | 2010-03-01 |